Evan on for Brandon Collard's questions to Repligen Corp (RGEN) leadership • Q3 2024
Question
Evan, on for Brandon Collard, inquired about how the strategy of pairing systems with proprietary consumables is helping gain market share and asked about the opportunity from a recent ATF design-in for a blockbuster drug.
Answer
President and CEO Olivier Loeillot explained the systems strategy creates a win-win by generating recurring consumable and service revenue while providing customers with state-of-the-art technology that improves productivity. He added that the blockbuster drug design-in is significant, securing not only large short-term equipment sales but also a long-term consumable stream.